Gabapentin Oral solution bulk supplier for pharma manufacturers

Gabapentin Oral Solution 250 mg/5 mL Suppliers & Bulk Manufacturers

Available Forms: Oral solution

Available Strengths: 250 mg/5 mL

Reference Brands: US: Neurontin®, Gralise®, Horizant® (ER); EU: Neurontin®, Gabantin®

Gabapentin (Neurontin®, Gralise®) is used for epilepsy, nerve pain, and RLS. Available in oral forms ranging from 100 mg to 800 mg, it's in high demand globally. Source Gabapentin API and finished products from trusted pharma suppliers via Pharmatradz.com—your B2B pharma trading network.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Gabapentin Oral Solution? List it or send an offer →

Product Description:

Gabapentin oral solution is FDA-approved in the USA for treating partial seizures and postherpetic neuralgia. It is available as a prescription medication under the Federal Food, Drug, and Cosmetic Act, with specific guidelines for renal dose adjustment and CNS-related adverse effects. In the European Union, gabapentin is authorized via national procedures for epilepsy and neuropathic pain, with country-specific brand names and formulations. EU labeling includes warnings for CNS depression, suicidal ideation, and withdrawal symptoms. It’s classified as a prescription-only medicine (POM).com

Gabapentin Oral Solution — third party manufacturing & bulk supply

Gabapentin Oral Solution 250 mg/5 mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Gabapentin Oral Solution is supplied as Oral solution — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Gabapentin Oral Solution listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Gabapentin Oral Solution →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Gabapentin Oral Solution is used to manage nerve pain (neuropathic pain) and to prevent seizures in patients with epilepsy. It is often prescribed for conditions such as postherpetic neuralgia, diabetic neuropathy, and partial-onset seizures. The oral solution form is particularly useful for patients who have difficulty swallowing tablets or require precise dose adjustments, including children and elderly patients.

It contains Gabapentin, an anticonvulsant and neuropathic pain agent. Gabapentin works by modulating calcium channels in the nervous system, which reduces abnormal nerve activity and alleviates pain and seizure episodes. The oral solution includes inactive ingredients to stabilize the formulation and make it palatable for easy administration.

Common trade names include Neurontin Oral Solution, Gralise Oral Solution, and Gabarone.

More than one company makes it, including manufacturers in India. Share your market and we will find licensed makers whose documents fit.

The generic name is Gabapentin Oral Solution.

Brand names include Neurontin Oral Solution, Gralise Oral Solution, and Gabarone.

It is manufactured in multiple countries including the USA, India, and Europe, and is distributed globally based on regulatory approvals and market demand.